144570-06-9

Basic information

• Product Name: Carbamic acid, [2-methyl-1-[(phenylmethoxy)methyl]propyl]-, 1,1-dimethylethyl ester, (R)-
• CAS NO: 144570-06-9
• Molecular Formula: C17H27NO3
• Molecular Weight: 293.406
• Mol File: 144570-06-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [2-methyl-1-[(phenylmethoxy)methyl]propyl]-, 1,1-dimethylethyl ester, (R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [2-methyl-1-[(phenylmethoxy)methyl]propyl]-, 1,1-dimethylethyl ester, (R)-(144570-06-9)
• EPA Substance Registry System: Carbamic acid, [2-methyl-1-[(phenylmethoxy)methyl]propyl]-, 1,1-dimethylethyl ester, (R)-(144570-06-9)

Safety Data

• Hazardous Substances Data: 144570-06-9(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 79069-14-0 tert-butyl [(1R)-1-(hydroxymethyl)-2-methylpropyl]carbamate 
• 7646-93-7 potassium hydrogensulfate 

Downstream Products

• 167486-39-7 tert-butyl (1,3-bis(benzyloxy)propan-2-yl)carbamate 
• 144570-07-0 O-Benzyl-(D)-valinol 

Relevant articles and documents

Macrocyclic difluorostatone derivatives useful as antiviral agents

The present invention provides novel macrocyclic difluorostatone derivatives which are useful as antiviral agents. More specifically, these novel compounds are useful as inhibitors of retroviral proteases required for replication, particularly the HIV-1 and HIV-2 viral proteases, in the prevention or treatment of infection by the human immunodeficiency virus (HIV), and in the treatment of consequent pathological conditions such as the acquired immunodeficiency syndrome (AIDS) in mammals capable of being infected with HIV virus.

Difluoro statone antiviral analogs

The present invention relates to difluorostatone derivatives useful as antiviral agents.